The United States health care system is at a pivotal point in its ability to manage chronic illness. The demands and philosophical differences between the management of acute and chronic illnesses suggest the need for different strategies for effective and efficient management of chronic illness. The purpose of this article is to discuss the Chronic Care Model and the collaborative approach to managing chronic illnesses. Asthma, as an exemplar, will be used to illustrate the need for the development of new models of collaborative care for the treatment of chronic illnesses.
Introduction
The management of acute illnesses has traditionally driven the development of the US health care system; however, in recent years, the impetus has significantly shifted to the management of chronic illnesses. 1 The shift is due to an increase in the occurrence of chronic and their associated illnesses, rising health care costs. 2, 3 The prevalence of chronic illness in the United States is reaching epidemic proportions-over 125 million Americans live with at least one chronic illness. 4 Annual health care expenditures in the United States are estimated to be $5274 per capita, with 78% of the expenditures specifically related to the management of chronic illness. 4, 5 Furthermore, increases in the prevalence and health care costs of chronic illness are expected to continue.
Despite the acute-to-chronic illness paradigm shift, the underlying philosophy of health care in the United States is slow to adopt chronic-care strategies that often deviate from the traditional acute-illness approach. Key distinctions between acute illnesses and chronic illnesses have generated different models of care. Acute and chronic illnesses can be differentiated by time and severity, with a severe and sudden onset associated with acute, but a long-developing progression associated with chronic illness. 6 Within the context of time and severity, the acute-illness approach does not foster patient participation in care; in contrast, the chronic-illness approach promotes the patient's participation and entails a multifaceted relationship between the patient and health care provider. 7, 8 In order to effectively and efficiently treat the rising incidence of chronic illnesses, moving from a focused, acute-illness model of care to a more collaborative, chronic-illness model is imperative.
Among the most prevalent chronic illnesses associated with high levels of morbidity in the United States, 9, 10 asthma is an excellent example of not only the rising incidence of chronic illnesses but also the need to adopt new care models that address the acute versus chronic illness paradigm shift. Therefore, following a discussion of the Chronic Care Model (CCM) and the collaborative approach to managing chronic illnesses, this article focuses on asthma as an exemplar of the need to develop new models of collaborative care for the treatment of chronic illnesses.
Background of chronic illness management
According to the Centers for Disease Control, 7 out of 10 deaths among Americans each year are due to a chronic disease. 11 The prevalence of chronic illness as a risk factor for death necessitates a shift from the traditional acute-illness model of care in the United States to an approach that includes the management of chronic illness. Currently, the US health care system is a high-tech, low-touch, capitalistic machine designed to respond to acute and life-threatening illnesses. Most acute illnesses are of a single etiologic nature that can be treated and cured. The management of acute illness is episodic, with little focus on teaching a patient to manage the illness due to its transient character. Referring back to the time and severity differentiation of acute versus chronic illness, effective treatment of an acute illness can be viewed as the resolution of the illness facilitated by the patient's compliance to the prescribed medical regimen. In contrast, chronic illness has a multiple and cumulative etiologic nature, which requires a multifactorial management approach that includes synergistic, collaborative relationships across many key stakeholders over time. 12 The chronic-illness approach not only promotes patient-centered management but also views effective treatment as promoting patient empowerment and supporting a mutual partnership between the patient and health care provider. 8 In order to effectively respond to both chronic and acute illnesses, the US health care system must transition to a high-tech, high-touch, sociocapitalistic machine.
However, developing a model of the processes and resources required to effectively and efficiently control chronic illness has posed a challenge for health care professionals and researchers. The management of chronic illness is complex and fraught with difficulties for numerous entities, including the health care system, health care providers, patients, and patients' family members. Nevertheless, the CCM and the collaborative management approaches to care have so far served as helpful guides in providing a multifactorial approach in the management of chronic illnesses. 13 The Chronic Care Model
The CCM is a heuristic model developed for use in multiple settings to understand the complex nature of chronic illnesses. [14] [15] [16] [17] The CCM originated from a review of the quality improvement literature and from quality improvement program activities at the Group Health Cooperative of Puget Sound located in Seattle, Washington. 14, 16 The CCM has been revised and compared to other competing care models for chronic illness 14, 16 and has also been implemented in over 300 health care systems to improve quality of care for chronic illnesses, including asthma, congestive heart failure, depression, diabetes, and frailty prevention in the elderly. 14, 18 The CCM is composed of three common but different realms: the community, the health care system, and the provider organization. 13, 14 The community encompasses the wealth of resources and policies to implement health care. The health care system is founded within the context of the payment structure to reimburse for health care. The provider organization provides the context of the delivery system to supply health care. The three realms provide a general structure to understand the embedded elements of managing chronic illness.
Within the CCM's realms are six essential elements: community resources and policies, the health care system, and the provider organization's self-management support, delivery system design, decision support, and clinical information. Self-management support is especially noteworthy because it entails a collaborative approach to care that empowers patients and families to manage chronic illness. Specifically, selfmanagement support views that patient as the expert and principal caregiver, while the health care provider serves in a supporting role. 3 In several recent studies, researchers have examined the efficacy of the CCM and reported promising, though perhaps inconclusive results. A 4-year qualitative study investigated health care organizations' implementation of CCM-based interventions for quality improvement. 19 Interventions were categorized into delivery system redesign, self-management strategies, decision support, information support, community linkages, and health system support. Although the study found evidence that suggests the CCM is a useful framework for quality improvement, it did not address health outcomes related to the illnesses included in the investigation. However, the study's researchers assured that a future publication of their ongoing investigation will be based on outcome analyses and will further detail the impact of the CCM on health outcomes.
Another group of researchers conducted a descriptive study of whether improvements in quality of patient care were associated with changes based on the application of the CCM. 20 Although the study's results suggested that health care organizations can successfully implement the CCM, no significant correlations were found between measures of the CCM implementation and quality improvements for patients with diabetes, heart disease, and depression. The study's authors suggested that the nonsignificant correlations could be a result of poor instrumentation or small effect sizes. Other possible explanations include the lack of a true effect to be measured and an inadequate sample size.
A systematic literature review of integrated quality management models compared the CCM with the Malcolm Baldrige Quality Award criteria and the European Foundation Quality Management Excellence Model. 21 In their review study, the authors included one meta-analysis, one systematic review, one randomized trial, five controlled studies, several case studies, and a few project reviews relating to the CCM. The meta-analysis by Tsai and colleagues 22 provided the strongest evidence in support of the CCM, with significant improvements in process outcome measures. Minkman and colleagues 21 suggested there was credible evidence, based on sound design and methods, to support interventions that use the CCM to improve clinical performance for patients with chronic illnesses.
In a recent systematic review performed by Adams and colleagues, 23 the literature was searched to answer the question about the CCM's effectiveness to prevent complications in chronic obstructive pulmonary disease patients. The authors found a limited number of studies (n ¼ 32) meeting criteria for inclusion (e.g. CCM component interventions, comparison groups or measures at two points, and relevant outcomes). Although the CCM did not impact symptoms, quality of life, lung function, or functional status, there was evidence to support benefit in decreasing risk of unscheduled visits (e.g. outpatient clinic and emergency room) and hospitalizations for those individuals receiving at least two of the CCM components.
There is evidence to support the CCM benefit in other chronic illnesses. In a recent review conducted by Dancer and Courtney, 24 evidence was sought to understand how the CCM improves outcomes for type 2 diabetes mellitus. This review focused on distinct elements of the CCM and their benefit and not the implementation of the CCM as a whole. The authors found evidence to support improved glycemic control (i.e. lower Hemoglobom Alc levels) associated with the use of various elements of the CCM. In a recent article by Bosworth et al., 25 self-management support as seen through the CCM was evaluated for hypertension and heart disease. In particular, interventions framed within the context of the CCM as selfmanagement support, such as monitoring blood pressure at home, may lower the blood pressure.
Self-management as collaborative management
As described earlier, one of the essential elements within the CCM's realms is self-management support, which promotes a collaborative relationship between an informed and activated patient and a prepared and proactive health care provider. Self-management support has been proposed as a vital component in the collaborative approach to the management of chronic illness. 26, 27 Collaborative management of chronic illness encourages the patient to perform self-care tasks, which include choosing and participating in healthy activities, fostering resilience, preventing sequelae, adhering to medical treatment, applying self-monitoring techniques, and managing effects of the illness. Collaborative management occurs when patients and their health care providers engage in behaviors that cultivate the following attributes: a sustained working relationship with each other, shared goals, a mutual understanding of health care roles and responsibilities, and the acquisition of required skills for goal attainment. 26 Barriers to collaborative management behaviors include the limited number of health care personnel who are trained in the collaborative approach to health care, the socialization of patient dependence on the health care provider, and the lack of insurance-based reimbursement for collaborative management education. 8 Much of the success of the collaborative approach to care depends on the patient's willingness to participate. Based on the Transtheoretical Model of behavior change, not everyone will be willing or able to modify his or her daily routine to incorporate selfmanagement of a chronic illness. [28] [29] [30] Therefore, health care providers must determine their patient's readiness for collaborative management and tailor interventions to facilitate the process. 31, 32 Patients are more apt to remember and employ tailored interventions leading to the likelihood of improving health outcomes. 33 Tailored interventions are based on both the Transtheoretical Model and the Health Belief Model which have made significant contributions in understanding how patients change behaviors to promote health. 34 Studies on health promotion and tertiary prevention have provided findings that suggest tailored interventions are not only efficacious but also effective. [35] [36] [37] [38] Nevertheless, tailored interventions are only as good as the health care system in which they are implemented. As it stands now, Medicare, Medicaid, and many health maintenance organizations (HMOs) do not reimburse for tailored self-management interventions. 8 Growing demands on HMOs may force them to change their policy. Tailored interventions that go beyond education to foster effective collaborative management of chronic illness will have to be supported by HMOs in the future to produce both cost reductions and positive health outcomes. 39 The implementation of and adherence to collaborative management of chronic illness is still a developing area of research. Health care systems and researchers need a better understanding of the multifactorial, dynamic process of the collaborative approach and how it can benefit outcomes. One area of health care that provides an example of the need to learn more about collaborative care is the management of asthma. Ongoing efforts to improve the treatment of asthmaincluding self-management support and a patienthealth care provider partnership in care-illustrate the importance of learning more about the collaborative approach to chronic illness.
Asthma exemplar
Asthma is a chronic relapsing and remitting inflammatory disease of the airways and is characterized by episodes of variable airflow obstruction and hyperresponsiveness that is often reversible. 12 Asthma is a global epidemic, with over 300 million individuals affected worldwide. 40 In the United States, asthma is one of the most prevalent chronic illnesses, affecting over 23.3 million Americans. 9 Asthma mortality rates are relatively low in the United States. In 2006, 3613 asthma-related deaths were reported, which represented a decrease from the 4099 deaths reported in 2003. 9 Although asthmarelated death rates have steadily declined over the past 10 years, asthma morbidity continues to be a significant health care burden. In 2006, there were 444,000 hospital discharges, 10.6 million health care provider office visits, 1.2 million hospital outpatient department visits, and 1.7 million emergency room visits attributable to asthma. 9 Costs related to asthma care are high in the United States. The direct medical expenditures are $15.6 billion annually; prescription medication expenditures are the largest portion of annual expenses at $5.6 billion. 9 The indirect costs such as morbidity, lost work productivity, and lost homemaking productivity bring the annual cost of asthma to over $16 billion. 9 Direct medical expenditures and indirect costs associated with asthma indicate the magnitude of asthma as a chronic illness and provide an impetus to maximize effective asthma treatment, including self-management.
Asthma treatment and health outcomes
Despite improved medication regimens, asthma morbidity remains high. Although there are many potential explanations, nonadherence to the medication regimen has been suggested as a key problem in the treatment of asthma. 41 Adherence is how well a patient follows a medication regimen that has been developed for them. 42 Medical nonadherence is a major public health problem that results in an estimated $100 billion spent each year in the United States. 43 Furthermore, nonadherence to medication regimen results in asthma exacerbation, emergency room visits, potential hospitalization, and even death. 41, 42, 44 An estimated 50% of asthma medications are not taken according to the medication regimen. 45 The reasons for nonadherence are varied. In adults, there is a fear of adverse effects of medications, beliefs of unhelpful or unneeded medications, a sense of intermittent need, a sense of inconvenience, difficulties due to the cost of the medications, dislike of the health care provider, a fear of stigmatization, a lack of knowledge, forgetfulness, a disbelief of the seriousness of asthma, a concern about medication tolerance, a fear of addiction, and the lack of social support. 45 When asthma is well managed, patients have fewer symptoms, use little to no reliever medication, and have productive and physically active lives, near normal lung function, and no serious asthma attacks. 40 Health outcomes may be conceptualized as indicators of the effectiveness of asthma management. Health outcomes in asthma management include such measures as symptom burden, health-related quality of life, health care utilization, medication adherence, and indicators of pulmonary function, such as peak expiratory flow and pulmonary function testing, or spirometry. 12, [46] [47] [48] [49] The National Asthma Education and Prevention Program (NAEPP) Expert Panel Report-3 (EPR-3), which was coordinated by the National Heart, Lung, and Blood Institute, presents well-developed practice guidelines that provide a framework for effective and efficient asthma management. The NAEPP EPR-3 practice guidelines are quite extensive and include the following topics: the definition of asthma, implications for treatment, the diagnosis of asthma, longterm management of asthma, and managing exacerbations. 12 Although the NAEPP EPR-3 practice guidelines do not specifically explain how to develop effective self-management empowerment strategies, two practice principles allude to the significance of self-management: (1) assessing and monitoring asthma severity and asthma control and (2) providing education for a partnership in care. 12 Extensive clinical research has investigated the efficacy of asthma self-management. Four Cochrane Collaboration systematic reviews examined 68 randomized controlled trials that were published between 1979 and 2001 and focused on education related to asthma self-management. [46] [47] [48] [49] Thirty-two studies did not meet the inclusion criteria and were excluded from the Cochrane systematic reviews. Findings revealed that asthma self-management strategies that empower the patient (e.g. written asthma action plans, symptom recognition education, medication education, and peak flow meter education) are effective in improving health outcomes. [46] [47] [48] [49] In contrast, another systematic review examined psychotherapeutic interventions for asthma and found they produce less favorable results than educational interventions. The review focused on the psychological dimension of asthma management to include behavioral interventions. Psychotherapeutic interventions presented in the review studies included cognitive behavioral therapy, cognitive therapy, behavioral therapy, relaxation therapy, supportive counseling, hypnosis, individual and group therapy formats, and patient education programs with a psychotherapy emphasis. Fleming et al. 50 found insufficient evidence to draw any definitive conclusions regarding the effectiveness of psychological interventions in asthma. The authors also reported that the inadequate number of studies (n ¼ 12) and the investigations' poor quality of study design, small sample sizes, diversity of interventions, and conflicting findings limited their systematic review.
The inadequate number of available studies for Fleming et al. 50 to review reflects the lack of literature that goes beyond the mere study of educational interventions to help patients self-manage their asthma. Although numerous studies have examined asthma self-management, the majority of research has focused only on education, medication, adherence to medical regimens, and barriers. Few studies have taken on a more comprehensive or global perspective of factors that affect asthma self-management, such as the patient-health care provider relationship.
Among the limited number of studies on the patient-health care provider partnership in asthma care, research have reported positive results. Findings suggest that developing a partnership in managing asthma holds valuable outcome benefits. 51, 52 Specifically, the continuity of care fostered by the provider in promoting a therapeutic partnership with an asthma patient has been shown to produce patient satisfaction, adherence to medication regimens, and appropriate health care utilization. 53 Research findings also indicate that the key to developing a therapeutic partnership between an asthma patient and health care provider is patient education. 54 Comprehensive asthma education is a combination of an asthma action plan for treatment and a daily selfmanagement plan. 51 The ultimate function of an asthma action plan is to encourage the patient to self-manage symptoms and medications, based on preplanned and written guidance from the health care provider. Because patient motivation is a function of knowledge and skill, which increases patient confidence and satisfaction, the health care provider's and patient's shared goal setting and decision making with regard to asthma care is imperative. 51 In this manner, self-management becomes collaborative management of asthma, in which the patient and health care provider participate in behaviors that cultivate shared goals, a mutual understanding of health care roles and responsibilities, skills for goal attainment, and a sustained working relationship.
The nature of the patient-health care provider partnership or collaborative relationship influences patient beliefs and behaviors, which in turn affect asthma self-management and health outcomes. 55 For example, the patient's perception of his or her relationship with the health care provider affects the patient's willingness to participate in the relationship. Specifically, a patient's perception of his or her health care provider's willingness to involve the patient in asthma self-management decisions is significantly associated with autonomy. 56 Asthma patients may want to contribute to asthma self-management decisions, but they tend to resist complete autonomous control. 57 Furthermore, an asthma patient's perceptions about his or her health care provider's competence, listening skills, and time management influence the patienthealth care provider partnership. 58 Although patients and health care providers want to develop a partnership to improve asthma health outcomes, study findings reveal a need to educate both the patient and the health care provider about partnerships. 59 
Discussion
The US health care system must balance managing chronic illnesses with managing acute illnesses. The CCM provides insight into the necessary components and their implementation in the management of chronic illness (see Improving Chronic Illness Care Web site for a CCM implementation toolkit). Of the CCM components, self-management support is one of the most imperative constructs as it relates to empowering and engaging patients in selfmanagement behaviors. Patients manage their chronic illness every day; however, how well they manage depends on the strength and characteristics of the patient-health care provider partnership. Effective and efficient management of chronic illness will not be through advances in medications alone. Arbitrary education about self-management will not lead to effective and efficient management of chronic illness either.
Collaborative management encompasses important attributes in the patient-health care provider relationship to effectively and efficiently self-manage chronic illness. Tailoring patient care based on patient preferences holds promise to improve mortality and morbidity associated with chronic illnesses. A consorted effort is needed to target those areas most likely to impact chronic illness mortality and morbidity. As described in asthma, the patient's perceptions about the patienthealth care provider relationship influence patient satisfaction, adherence to medication regimens, and appropriate health care utilization. Educating both patients and health care providers about the collaborative management approach (i.e. goal setting, role delineation, responsibility allocation, skill acquisition and implementation, and a long-standing patient-health care provider relationship) to chronic illness may extend benefits already seen in previous research.
